Compositions and methods for treatment of exocrine pancreatic insufficiency (epi)

3:

• The method of claim 2, the method comprising administering to the individual the nutritional composition comprising all of the characteristics (i)-(vii).

4:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat further comprising an additional fat that is selected from the group consisting of diacylglycerols (DAG), long chain triglycerides (LCT), medium chain triglycerides (MCT), short chain fatty acids (SCFA), branched chain fatty acids (BCFA), structured MAG, structured DAG, free fatty acids, bound fatty acids, phospholipids, lyso-phospholipids, sphingomyelin, gangliosides, specialized pro-resolving mediators (SPMs), and mixtures thereof.

5:

• The method of claim 1, further comprising detecting the EPI in the patient before the administering the nutritional composition to the individual.

6:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having an energy density of 1.0-2.0 kcal/ml.

7:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat comprising the MAG that is at least 40 wt % of the total fat.

8:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat consisting of the MAG.

9:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat that does not contain any MCT.

10:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat that comprises the MAG;
• and further comprises LCT in an amount from 10 wt % to 30 wt % of the total fat.

11:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat that comprises the MAG;
• and further comprises less than 5.0 wt % LCT relative to the total fat.

12:

• The method of claim 1, the method comprising administering to the individual the nutritional composition having the total fat comprising a combination of free fatty acids and the MAG.

13:

• The method of claim 1, the method comprising administering to the individual the nutritional composition that does not contain any phospholipids.

14:

• The method of claim 1, the method comprising administering to the individual the nutritional composition that is selected from the group consisting of a tube feed, a food product, a food supplement, an oral nutritional supplements (ONS), a medical food, and combinations thereof.

16:

• The method of claim 15, the method comprising administering to the individual the nutritional composition comprising all of the characteristics (i)-(vii).